4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Nipocalimab: new trials by email Literature Review of Nipocalimab trials Research Report on Nipocalimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis Placebo, Nipocalimab, Certolizumab - Arthritis, Rheumatoid | Phase 2 | Completed | Janssen Research & Development, LLC | 103 | 2023-08-15 | 2025-10-16 |
| A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis Placebo, Nipocalimab - Arthritis, Rheumatoid | Phase 2 | Completed | Janssen Research & Development, LLC | 53 | 2021-10-14 | 2025-08-22 |
| A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) Placebo, Nipocalimab, Standard of Care Treatment - Sjogren's Syndrome | Phase 2 | Completed | Janssen Research & Development, LLC | 163 | 2021-09-21 | 2025-11-05 |
| A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus Placebo, Nipocalimab, Standard-of-care treatment - Systemic Lupus Erythematosus | Phase 2 | Completed | Janssen Research & Development, LLC | 228 | 2021-08-20 | 2025-12-08 |
Arthritis, Rheumatoid (2) · Lupus Erythematosus, Systemic (1) · Sjogren's Syndrome (1)
Janssen Research & Development, LLC (4)
Germany (4) · Poland (4) · United States (4) · Spain (3) · Argentina (2) · Hungary (2) · Japan (2) · Taiwan (2) · United Kingdom (2) · Bulgaria (1) · Colombia (1) · France (1) · Italy (1) · Netherlands (1) · Portugal (1)
PMID 42084498, PMID 38942592, PMID 41284548, PMID 41781163
2023 (1)